MoneyWorks4Me

Alivus Life Sciences informs about newspaper publication

13 Aug 2026 Evaluate
Pursuant to Regulation 47 read with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Alivus Life Sciences has enclosed copies of newspaper advertisement published in Financial Express (English) and Loksatta (Marathi) which includes the following information: Intimation of 15th AGM of the Company to be held through Video Conferencing (VC) / Other Audio-Visual Means (OAVM) and confirmation of email dispatch of Notice of AGM and the Integrated Annual Report for the Financial Year 2025-26; and particulars of the facility of e-voting provided to Shareholders of the Company to enable them to cast their votes on the resolutions proposed to be passed at the AGM.

The above information is a part of company’s filings submitted to BSE.

Alivus Life Sciences Share Price

1384.30 10.75 (0.78%)
14-Aug-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1924.90
Dr. Reddys Labs. 1202.00
Cipla 1450.00
Lupin 2235.00
Zydus Lifesciences 1140.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: